EGFR突变非小细胞肺癌伴获得性BRAF改变患者的三靶点治疗特征与疗效
Features and efficacy of triple-targeted therapy for patients with EGFR-mutant non-small-cell lung cancer with acquired BRAF alterations who are resistant to epidermal growth factor receptor tyrosine kinase inhibitors
DOI 原文链接
用sci-hub下载
如无法下载,请从 Sci-Hub 选择可用站点尝试。
正在获取期刊数据...
发表日期:2024 Oct
作者:
DOI:10.1016/j.esmoop.2024.103935
摘要
AI正在翻译并加载中文摘要...